• NADPH Oxidase, ROS, and L-Type Ca2+ Channels in Postnatal Ar

  2026-06-02

  This study elucidates how NADPH oxidase-derived reactive oxygen species (ROS) enhance peripheral arterial contraction in early postnatal rats primarily through activation of L-type voltage-gated Ca2+ channels. The findings clarify that, unlike in adults, this procontractile effect in young rats is independent of Rho-kinase, PKC, or Src-kinase activity, refining our mechanistic understanding of vascular development.

• Arachidonic Acid in Immune Modulation: Mechanisms and Resear

  2026-06-02

  Explore the pivotal role of arachidonic acid, a polyunsaturated omega-6 fatty acid, in immune signaling and advanced biomedical research. This article delivers unique mechanistic insights and protocol guidance, going beyond supplementation to inform experimental design.

• Recombinant Mouse M-CSF without Tag: Mechanistic Insight & A

  2026-06-01

  Explore the mechanistic role of Recombinant Mouse Macrophage Colony Stimulating Factor (M-CSF) without Tag in macrophage-driven fibrosis and advanced immunometabolic assays. This in-depth analysis offers assay designers a unique lens on M-CSF’s applications and the latest IGF2BP1-THBS1 axis findings.

• H-Aggregated NIR-II Fluorophores for Enhanced Cancer PTT

  2026-06-01

  Yu et al. developed a lipid nanosystem that delivers H-aggregated NIR-II fluorophores to tumor cell membranes, enabling both high-contrast imaging and efficient photothermal therapy. This strategy addresses the challenge of combining strong fluorescence with stable photothermal conversion, paving the way for more effective, synergistic cancer treatment modalities.

• Biotin-tyramide (A8011): Advancing Reliable Signal Amplifica

  2026-05-31

  This scenario-driven article examines how Biotin-tyramide (SKU A8011) addresses core challenges in sensitive cell-based assays and spatial omics. Drawing on peer-reviewed data and validated protocols, we demonstrate why this reagent delivers reproducibility and precision for biomedical researchers.

• Veratridine (SKU B7219): Precision in Sodium Channel Researc

  2026-05-30

  This article addresses common laboratory challenges in cell viability and sodium channel dynamics research, demonstrating how Veratridine (SKU B7219) delivers reproducible, data-driven solutions. Drawing on published literature and APExBIO’s product dossier, it guides biomedical scientists through real-world experimental scenarios, protocol optimization, and reliable vendor selection.

• Transdermal PTEN mRNA Delivery via HA-LNPs for Melanoma Ther

  2026-05-29

  A 2025 study introduces hyaluronated lipid nanoparticles (HA-LNPs) for non-invasive, transdermal delivery of PTEN mRNA, enabling restoration of tumor suppressor function and enhanced antitumor immunity in melanoma. This work demonstrates a clinically-relevant platform for targeted mRNA cancer immunotherapy with improved biocompatibility and immune activation.

• In Vitro Metrics for Drug Response: Lessons from Cancer Rese

  2026-05-29

  Schwartz's dissertation advances in vitro evaluation of anti-cancer drug responses by rigorously dissecting the distinction and interplay between relative viability and fractional viability metrics. These methodological insights inform more precise characterization of compounds like Cediranib (AZD2171) in angiogenesis and cancer signaling studies.

• EdU Imaging Kits (Cy3): Precision Cell Proliferation Analysi

  2026-05-28

  EdU Imaging Kits (Cy3) deliver high-sensitivity, denaturation-free detection of S-phase DNA synthesis, offering a superior alternative to BrdU for fluorescence microscopy and flow cytometry. Their streamlined workflow and low-background Cy3 signal empower researchers to quantify cell proliferation and genotoxicity with unmatched clarity—even in challenging cancer models like glioblastoma.

• Axitinib (AG 013736): Optimizing VEGF Pathway Inhibition Ass

  2026-05-28

  Axitinib (AG 013736) stands out as a gold-standard, highly selective VEGFR inhibitor, enabling precise angiogenesis and tumor growth inhibition studies. This guide translates advanced in vitro and in vivo research workflows, troubleshooting approaches, and recent dual-metric evaluation innovations into actionable protocols for cancer biology research.

• Salvianolic Acid A Targets GOT2 to Alleviate Doxorubicin Car

  2026-05-27

  This study identifies glutamic-oxaloacetic transaminase 2 (GOT2) as a direct target of salvianolic acid A (SAA) and demonstrates its role in mitigating doxorubicin-induced myocardial oxidative injury. By activating the malate-aspartate NADH shuttle, SAA preserves cardiac function and reduces oxidative stress, highlighting a potential therapeutic strategy for cardioprotection during chemotherapy.

• Dual-Action Inhibition Enhances p38α MAPK Dephosphorylation

  2026-05-27

  This study uncovers how certain kinase inhibitors, by stabilizing inactive activation loop conformations, not only block p38α MAPK activity but also accelerate its dephosphorylation by phosphatases. The findings provide a structural and mechanistic basis for designing inhibitors that combine kinase blockade with enhanced phosphatase-driven inactivation, informing next-generation strategies in inflammation and diabetes research.

• Ribonuclease R (RNase R) (20 U/μL): Circular RNA Enrichment

  2026-05-26

  Ribonuclease R (RNase R) (20 U/μL) is a processive exoribonuclease enabling selective linear RNA degradation, which facilitates accurate circular RNA enrichment and analysis. The enzyme is essential for dissecting RNA structure-function relationships, particularly in inflammation and DNA damage research. Its stability, specificity, and proven use in recent mechanistic studies distinguish it as a benchmark tool for RNA metabolism investigations.

• Vitamin C (CAS 50-81-7): Integrative Anticancer and Antivira

  2026-05-26

  Explore the advanced biomedical applications of Vitamin C (ascorbic acid) as both an anticancer agent and a tool in next-generation organoid-based antiviral models. This article uniquely merges mechanistic detail with practical assay strategies, offering insights not found in current literature.

• Berberrubine Chloride: Protocol Optimization in Cancer & Inf

  2026-05-25

  Berberrubine chloride (9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride) uniquely enables multi-pathway targeting in cancer and inflammatory disease models. This article unpacks stepwise protocols, troubleshooting, and workflow synergies based on leading-edge research and APExBIO’s high-quality supply.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page